Preclinical studies demonstrated that TGFα-immunotoxins are highly cytotoxic to bladder cancer cells and patient bladder cancer explants, despite the lack of EGFR amplification in these cells [87,88]. This evidence concerns the gene EGFR and urinary bladder carcinoma.